Study of Triamcinolone Acetonide on the Growth Velocity of Children, Ages 3 to 9, With Perennial Allergic Rhinitis (PAR)

Clinical trial NCT00449072 · COMPLETED

Trial details

NCT number: NCT00449072
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Rhinitis, Allergic, Perennial

Start date: 2007-03-01
Primary completion: 2011-10-01
Enrollment: 299

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.